首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Interaction of TIF-90 and filamin A in the regulation of rRNA synthesis in leukemic cells
【24h】

Interaction of TIF-90 and filamin A in the regulation of rRNA synthesis in leukemic cells

机译:TIF-90和纤维蛋白A在白血病细胞rRNA合成调控中的相互作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The transcription initiation factor I (TIF-IA) is an important regulator of the synthesis of ribosomal RNA (rRNA) through its facilitation of the recruitment of RNA polymerase I (Pol I) to the ribosomal DNA promoter. Activation of the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway, which occurs commonly in acute myelogenous leukemia, enhances rRNA synthesis through TIF-IA stabilization and phosphorylation. We have discovered that TIF-IA coexists with a splicing isoform, TIF-90, which is expressed preferentially in the nucleolus and at higher levels in proliferating and transformed hematopoietic cells. TIF-90 interacts directly with Pol I to increase rRNA synthesis as a consequence of Akt activation. Furthermore, TIF-90 binds preferentially to a 90-kDa cleavage product of the actin binding protein filamin A (FLNA) that inhibits rRNA synthesis. Increased expression of TIF-90 overcomes the inhibitory effect of this cleavage product and stimulates rRNA synthesis. Because activated Akt also reduces FLNA cleavage, these results indicate that activated Akt and TIF-90 function in parallel to increase rRNA synthesis and, as a consequence, cell proliferation in leukemic cells. These results provide evidence that the direct targeting of Akt would be an effective therapy in acute leukemias in which Akt is activated.
机译:转录起始因子I(TIF-IA)通过促进RNA聚合酶I(Pol I)募集到核糖体DNA启动子,是核糖体RNA(rRNA)合成的重要调节剂。磷酸肌醇3激酶(PI3K)/蛋白激酶B(Akt)途径的激活(通常发生在急性骨髓性白血病中)通过TIF-IA稳定和磷酸化增强rRNA的合成。我们已经发现TIF-IA与剪接同工型TIF-90共存,TIF-90优先在核仁中表达,并在增殖和转化的造血细胞中以较高的水平表达。由于Akt激活,TIF-90与Pol I直接相互作用以增加rRNA的合成。此外,TIF-90优先结合肌动蛋白结合蛋白丝素A(FLNA)的90 kDa裂解产物,该产物抑制rRNA合成。 TIF-90表达的增加克服了这种裂解产物的抑制作用,并刺激了rRNA的合成。由于活化的Akt也会减少FLNA裂解,因此这些结果表明,活化的Akt和TIF-90并行发挥作用,以增加rRNA的合成,从而增加白血病细胞的细胞增殖。这些结果提供了证据,表明直接靶向Akt在激活Akt的急性白血病中将是一种有效的疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号